(Q48487650)

12 February 2018

title

Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients (English)

1 reference

12 February 2018

1 reference

A F Carpentier

1

1 reference

12 February 2018

D Ferrari

2

1 reference

12 February 2018

O Bailon

3

1 reference

12 February 2018

R Ursu

4

1 reference

12 February 2018

C Banissi

5

1 reference

12 February 2018

A-L Dubessy

6

1 reference

12 February 2018

C Belin

7

1 reference

12 February 2018

C Levy

8

1 reference

12 February 2018

publication date

31 May 2012

1 reference

12 February 2018

European Journal of Neurology

published in

1 reference

12 February 2018

volume

19

1 reference

12 February 2018

issue

10

1 reference

12 February 2018

page(s)

1337-1342

1 reference

12 February 2018

Primary brain tumours in adults.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Steroid requirements during radiotherapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

The use and toxicity of steroids in the management of patients with brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Blood-brain barrier breakdown in septic encephalopathy and brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03766.X

10.1111/J.1468-1331.2012.03766.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018